Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2004-3-18
pubmed:abstractText
In pithed spontaneous hypertensive rats, noradrenaline overflow was diminished by moxonidine even when alpha(2)-adrenoceptors were blocked quantitatively using phenoxybenzamine, suggesting an I(1)-receptor-mediated mechanism of noradrenaline release. This hypothesis was confirmed, since the noradrenaline overflow was (1) increased under alpha(2)-adrenoceptors blockade by the mixed I(1)/alpha(2)-antagonists efaroxan or idazoxan, (2) still reduced by moxonidine when both alpha(2)- and I(1)-receptors were blocked, and (3) diminished by agmatine after pretreatment with phenoxybenzamine, but not with AGN192403. An indirect ganglionic I(1)-receptor-mediated mechanism of noradrenaline release is supposed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AGN 192403, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Agmatine, http://linkedlifedata.com/resource/pubmed/chemical/Benzofurans, http://linkedlifedata.com/resource/pubmed/chemical/Bicyclo Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Heptanes, http://linkedlifedata.com/resource/pubmed/chemical/Idazoxan, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoline Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Phenoxybenzamine, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Drug, http://linkedlifedata.com/resource/pubmed/chemical/efaroxan, http://linkedlifedata.com/resource/pubmed/chemical/imidazoline I1 receptors, http://linkedlifedata.com/resource/pubmed/chemical/moxonidine
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0077-8923
pubmed:author
pubmed:issnType
Print
pubmed:volume
1009
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
270-3
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15028598-Adrenergic alpha-Antagonists, pubmed-meshheading:15028598-Agmatine, pubmed-meshheading:15028598-Animals, pubmed-meshheading:15028598-Benzofurans, pubmed-meshheading:15028598-Bicyclo Compounds, pubmed-meshheading:15028598-Blood Pressure, pubmed-meshheading:15028598-Electric Stimulation, pubmed-meshheading:15028598-Heptanes, pubmed-meshheading:15028598-Hypertension, pubmed-meshheading:15028598-Idazoxan, pubmed-meshheading:15028598-Imidazoles, pubmed-meshheading:15028598-Imidazoline Receptors, pubmed-meshheading:15028598-Male, pubmed-meshheading:15028598-Norepinephrine, pubmed-meshheading:15028598-Phenoxybenzamine, pubmed-meshheading:15028598-Rats, pubmed-meshheading:15028598-Rats, Inbred SHR, pubmed-meshheading:15028598-Receptors, Adrenergic, alpha-2, pubmed-meshheading:15028598-Receptors, Drug, pubmed-meshheading:15028598-Spinal Cord
pubmed:year
2003
pubmed:articleTitle
Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors.
pubmed:affiliation
Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Schleswig-Holstein, Campus Lübeck, Germany. raasch@medinf.mu-luebeck.de
pubmed:publicationType
Journal Article